US EditionPublished • loading... • Updated
Alzheimer: Flav-27 Reverses Cognitive Decline in Mice by Targeting Epigenoma
Summary by Fredzone
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Research on Alzheimer's disease may have reached a decisive stage. Researchers at the Institute of Neurosciences at the University of Barcelona have developed a novel compound, called FLAV-27, whose results on animal models are particularly encouraging. Unlike the existing treatments that target proteins associated with the disease, this new ... Read more The Alzheimer's article: FLAV-27 reverses cognitive decline in mice by targeting epigenoma …
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
